Middle school students co-author research on enzyme for activating promising disease-fighters

It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry. The student co-authors of the study are from Edgewood Campus Middle School in Madison and participated in Project CRYSTAL, a special program that provides middle school students with hands-on laboratory experience.

In the report, study leader Hazel Holden and colleagues note intense scientific interest in a chemical process called methylation, which increases the activity of DNA, proteins, and other substances in the body by transferring methyl (CH3) groups to them. Special enzymes called methyltransferases make methylation possible, and these proteins are very important in a myriad of key biological processes.

Holden and colleagues studied a bacterial methyltransferase involved in the production of tetronitrose, a component of the promising anti-cancer agent, tetrocarcin, and the antibiotic kijanimicin. The methyltransferase seems to play a key role in activating these disease-fighters. The scientists identified the 3D structure of this methyltransferase, a key step in determining how it works and how it might be modified for potential use in medicine.

ARTICLE FOR IMMEDIATE RELEASE “Molecular Architecture of a C-3'-Methyltransferase Involved in the Biosynthesis of D-Tetronitrose”

DOWNLOAD FULL TEXT ARTICLE http://pubs.acs.org/stoken/presspac/presspac/full/10.1021/bi100782b

CONTACT:
Hazel Holden, Ph.D.
Department of Biochemistry
University of Wisconsin
Madison, Wisc. 53706
Phone: 608-262-4988
Fax: 608-262-1319
Email: Hazel_Holden@biochem.wisc.edu